176 related articles for article (PubMed ID: 38233078)
1. Association between brain imaging biomarkers and continuous glucose monitoring-derived glycemic control indices in Japanese patients with type 2 diabetes mellitus.
Inoue C; Kusunoki Y; Ohigashi M; Osugi K; Kitajima K; Takagi A; Inoue M; Yagi C; Tsunoda T; Kakutani M; Kadoya M; Konishi K; Katsuno T; Koyama H; ;
BMJ Open Diabetes Res Care; 2024 Jan; 12(1):. PubMed ID: 38233078
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Glycemia Risk Index with Time in Range for Assessing Glycemic Quality.
Kim JY; Yoo JH; Kim JH
Diabetes Technol Ther; 2023 Dec; 25(12):883-892. PubMed ID: 37668665
[No Abstract] [Full Text] [Related]
3. Relationship between key continuous glucose monitoring-derived metrics and specific cognitive domains in patients with type 2 diabetes mellitus.
Dong S; Wang L; Zhao C; Zhang R; Gao Z; Jiang L; Guo Y; Zhou H; Xu S
BMC Neurol; 2023 May; 23(1):200. PubMed ID: 37210479
[TBL] [Abstract][Full Text] [Related]
4. Association between low-carbohydrate diets and continuous glucose monitoring-derived time in ranges.
Osugi K; Kusunoki Y; Ohigashi M; Kusunoki K; Inoue C; Inoue M; Takagi A; Tsunoda T; Kadoya M; Konishi K; Katsuno T; Koyama H;
J Diabetes Investig; 2023 May; 14(5):659-668. PubMed ID: 38078864
[TBL] [Abstract][Full Text] [Related]
5. Association of Body Fat Percentage with Time in Range Generated by Continuous Glucose Monitoring during Continuous Subcutaneous Insulin Infusion Therapy in Type 2 Diabetes.
Ruan Y; Zhong J; Chen R; Zhang Z; Liu D; Sun J; Chen H
J Diabetes Res; 2021; 2021():5551216. PubMed ID: 34136580
[TBL] [Abstract][Full Text] [Related]
6. The Glycemia Risk Index Predicts Performance of Diabetes Self-Management Habits in Youth With Type 1 Diabetes Mellitus.
Panfil K; Vandervelden CA; Lockee B; Tallon EM; Williams DD; Lee JM
J Diabetes Sci Technol; 2024 Jul; 18(4):779-786. PubMed ID: 38708581
[TBL] [Abstract][Full Text] [Related]
7. THE ADDED AND INTERPRETATIVE VALUE OF CGM-DERIVED PARAMETERS IN TYPE 1 DIABETES DEPENDS ON THE LEVEL OF GLYCEMIC CONTROL.
Helleputte S; De Backer T; Calders P; Pauwels B; Shadid S; Lapauw B
Endocr Pract; 2021 Jan; 27(1):44-50. PubMed ID: 33475500
[TBL] [Abstract][Full Text] [Related]
8. Association between continuous glucose monitoring-derived glycemic control indices and urinary biomarkers of diabetic kidney disease: Hyogo Diabetes Hypoglycemia Cognition Complications study.
Takagi A; Kusunoki Y; Ohigashi M; Osugi K; Inoue C; Inoue M; Tsunoda T; Kadoya M; Konishi K; Katsuno T; Koyama H;
Acta Diabetol; 2024 Apr; 61(4):413-423. PubMed ID: 38006524
[TBL] [Abstract][Full Text] [Related]
9. Impact of glucose variability on the assessment of the glycemia risk index (GRI) and classic glycemic metrics.
Pérez-López P; Férnandez-Velasco P; Bahillo-Curieses P; de Luis D; Díaz-Soto G
Endocrine; 2023 Dec; 82(3):560-568. PubMed ID: 37695452
[TBL] [Abstract][Full Text] [Related]
10. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis.
Keyu G; Jiaqi L; Liyin Z; Jianan Y; Li F; Zhiyi D; Qin Z; Xia L; Lin Y; Zhiguang Z
Front Public Health; 2022; 10():990281. PubMed ID: 36091534
[TBL] [Abstract][Full Text] [Related]
11. Association between glycemic control assessed by continuous glucose monitoring and stroke in patients with atrial fibrillation and diabetes mellitus.
Guo J; Wang J; Zhao Z; Yu L
Ann Palliat Med; 2021 Aug; 10(8):9157-9164. PubMed ID: 34488401
[TBL] [Abstract][Full Text] [Related]
12. Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - Pump vs multiple daily injections, a secondary analysis of an observational cohort study.
Kjölhede K; Berntorp K; Kristensen K; Katsarou A; Shaat N; Wiberg N; Knop FK; Kristensen L; Dotevall A; Elfvin A; Sandgren U; Sengpiel V; Englund-Ögge L
Acta Obstet Gynecol Scand; 2021 May; 100(5):927-933. PubMed ID: 33176006
[TBL] [Abstract][Full Text] [Related]
13. Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials.
Maiorino MI; Signoriello S; Maio A; Chiodini P; Bellastella G; Scappaticcio L; Longo M; Giugliano D; Esposito K
Diabetes Care; 2020 May; 43(5):1146-1156. PubMed ID: 32312858
[TBL] [Abstract][Full Text] [Related]
14. [Neural networks in the predictive diagnosis of cognitive impairment in type 1 and type 2 diabetes mellitus].
Samoilova IG; Matveeva MV; Kudlay DA; Tonkikh OS; Tolmachev IV
Ter Arkh; 2021 Nov; 93(11):1349-1358. PubMed ID: 36286658
[TBL] [Abstract][Full Text] [Related]
15. Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes.
Lu J; Ma X; Zhou J; Zhang L; Mo Y; Ying L; Lu W; Zhu W; Bao Y; Vigersky RA; Jia W
Diabetes Care; 2018 Nov; 41(11):2370-2376. PubMed ID: 30201847
[TBL] [Abstract][Full Text] [Related]
16. Effects of structured Ramadan Nutrition Plan on glycemic control and variability using continuous glucose monitoring in individuals with type 2 diabetes: A pilot study.
Hasbullah FY; Mohd Yusof BN; Wan Zukiman WZHH; Abu Zaid Z; Omar N; Liu RXY; Marczewska A; Hamdy O
Diabetes Metab Syndr; 2022 Oct; 16(10):102617. PubMed ID: 36174477
[TBL] [Abstract][Full Text] [Related]
17. Relationship between daily and visit-to-visit glycemic variability in patients with type 2 diabetes.
Tsuchiya T; Saisho Y; Murakami R; Watanabe Y; Inaishi J; Itoh H
Endocr J; 2020 Aug; 67(8):877-881. PubMed ID: 32389920
[TBL] [Abstract][Full Text] [Related]
18. Association of Time in Range levels with Lower Extremity Arterial Disease in patients with type 2 diabetes.
Li J; Li Y; Ma W; Liu Y; Yin X; Xie C; Bai J; Zhang M
Diabetes Metab Syndr; 2020; 14(6):2081-2085. PubMed ID: 33137566
[TBL] [Abstract][Full Text] [Related]
19. The effect of continuous glucose monitoring-guided glycemic control on progression of coronary atherosclerosis in type 2 diabetic patients with coronary artery disease: The OPTIMAL randomized clinical trial.
Kataoka Y; Kitahara S; Funabashi S; Makino H; Matsubara M; Matsuo M; Omura-Ohata Y; Koezuka R; Tochiya M; Tamanaha T; Tomita T; Honda-Kohmo K; Noguchi M; Maruki M; Kanai E; Murai K; Iwai T; Sawada K; Matama H; Honda S; Fujino M; Yoneda S; Takagi K; Otsuka F; Asaumi Y; Hosoda K; Nicholls SJ; Yasuda S; Noguchi T
J Diabetes Complications; 2023 Oct; 37(10):108592. PubMed ID: 37741088
[TBL] [Abstract][Full Text] [Related]
20. Beyond HbA1c: Comparing Glycemic Variability and Glycemic Indices in Predicting Hypoglycemia in Type 1 and Type 2 Diabetes.
Rama Chandran S; Tay WL; Lye WK; Lim LL; Ratnasingam J; Tan ATB; Gardner DSL
Diabetes Technol Ther; 2018 May; 20(5):353-362. PubMed ID: 29688755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
